HEART FAILURE WITH MODERATELY REDUCED EJECTION FRACTION
Clinical trials for HEART FAILURE WITH MODERATELY REDUCED EJECTION FRACTION explained in plain language.
Never miss a new study
Get alerted when new HEART FAILURE WITH MODERATELY REDUCED EJECTION FRACTION trials appear
Sign up with your email to follow new studies for HEART FAILURE WITH MODERATELY REDUCED EJECTION FRACTION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart device trial aims to boost function in patients with preserved pumping ability
Disease control Recruiting nowThis study tests a small implanted device that sends gentle electrical signals to strengthen heart contractions in people with heart failure whose hearts still pump fairly well (ejection fraction 40-70%). Researchers will compare the device to a sham (inactive) implant in 1,500 p…
Matched conditions: HEART FAILURE WITH MODERATELY REDUCED EJECTION FRACTION
Phase: NA • Sponsor: Impulse Dynamics • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
Can a new drug combo outperform standard care for a common type of heart failure?
Disease control Recruiting nowThis trial is testing whether sacubitril/valsartan, a newer heart failure medication, can improve heart function and reduce harmful heart remodeling better than the older drug ramipril. The study enrolls adults with ischemic heart failure (caused by reduced blood flow to the hear…
Matched conditions: HEART FAILURE WITH MODERATELY REDUCED EJECTION FRACTION
Phase: PHASE3 • Sponsor: John Paul II Hospital, Krakow • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC